COO vs EBS · P/E 36, rev $4.09B vs rev $1.04B
The Cooper Companies, Inc (COO) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. Revenue was up 5.1% from 2024-10-31 to 2025-10-31. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. EBS currently screens at market cap $416.4M.
Not investment advice. Open the COO and EBS stock pages for the full models.
Not investment advice.